Diabetes treatment in two pregnant women with permanent neonatal diabetes mellitus due to a KCNJ11 mutation.
作者信息
Stanik J, Barak L, Dankovcikova A, Valkovicova T, Skopkova M, Gasperikova D
机构信息
DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Centre of Slovak Academy of Sciences, Bratislava.
Children Diabetes Centre of the Slovak Republic at the Department of Paediatrics, Medical Faculty of Comenius University and National Institute for Children´s Diseases, Bratislava.
出版信息
Diabet Med. 2020 Nov;37(11):1956-1958. doi: 10.1111/dme.14363. Epub 2020 Jul 20.
PMID:32634858
Abstract
摘要
相似文献
1
Diabetes treatment in two pregnant women with permanent neonatal diabetes mellitus due to a KCNJ11 mutation.两名因KCNJ11突变导致永久性新生儿糖尿病的孕妇的糖尿病治疗
Diabet Med. 2020 Nov;37(11):1956-1958. doi: 10.1111/dme.14363. Epub 2020 Jul 20.
2
Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation.短暂性新生儿糖尿病与复发性（R201H）KCNJ11（KIR6.2）突变相关。
Diabetologia. 2005 Nov;48(11):2439-41. doi: 10.1007/s00125-005-1958-1. Epub 2005 Oct 5.
3
Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.一名因KCNJ11激活突变导致永久性新生儿糖尿病的婴儿从皮下注射胰岛素转换为口服格列本脲的门诊过渡治疗。
Pediatr Diabetes. 2008 Jun;9(3 Pt 1):236-9. doi: 10.1111/j.1399-5448.2007.00316.x. Epub 2008 Jan 24.
4
No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes.在接受格列本脲治疗中位时间为68个月的KCNJ11相关永久性新生儿糖尿病患者中，未出现β细胞脱敏现象。
Diabetologia. 2011 Oct;54(10):2736-8. doi: 10.1007/s00125-011-2273-7. Epub 2011 Aug 7.
5
Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation.一名因KCNJ11 F333L[已修正]突变导致单基因新生儿糖尿病的患者成功从胰岛素治疗过渡到磺脲类药物治疗。
Diabetes Care. 2013 Dec;36(12):e201. doi: 10.2337/dc13-1690.
6
Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control.磺酰脲类药物与胰岛素治疗对 KCNJ11 基因突变导致的磺酰脲类药物敏感的永久性新生儿糖尿病，以及血糖控制不佳的个体。
Diabet Med. 2018 Mar;35(3):386-391. doi: 10.1111/dme.13575.
7
Sulfonylurea-responsive diabetes in childhood.儿童磺脲类药物反应性糖尿病
J Pediatr. 2007 May;150(5):553-5. doi: 10.1016/j.jpeds.2007.03.004.
8
First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment.首例 KCNJ11 Q52R 突变导致的新生儿糖尿病经磺脲类药物成功转换治疗。
J Diabetes Investig. 2017 Sep;8(5):716-719. doi: 10.1111/jdi.12620. Epub 2017 Feb 16.
9
Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.成功用磺酰脲类药物治疗因 KCNJ11 新突变导致的新生儿糖尿病的新生儿。
Diabetes Res Clin Pract. 2011 Jan;91(1):e1-3. doi: 10.1016/j.diabres.2010.09.027. Epub 2010 Nov 5.
10
Successful sulfonylurea treatment of an insulin-naïve neonate with diabetes mellitus due to a KCNJ11 mutation.成功使用磺酰脲类药物治疗因 KCNJ11 突变导致的胰岛素初治新生儿糖尿病。
Pediatr Diabetes. 2010 Jun;11(4):286-8. doi: 10.1111/j.1399-5448.2009.00557.x. Epub 2009 Jul 29.
引用本文的文献
1
Effect of Continuous Subcutaneous Injection of Insulin Analogues in Pregnant Women with Diabetes Mellitus Complicated with Ketoacidosis.糖尿病酮症酸中毒孕妇连续皮下注射胰岛素类似物的效果。
J Healthc Eng. 2021 Dec 15;2021:8670474. doi: 10.1155/2021/8670474. eCollection 2021.
Zotero 插件